RegeneRx Receives Ophthalmic Patent in Hong Kong (Business Wire via Yahoo!7 Finance)
RegeneRx Receives Ophthalmic Patent in Hong Kong (Business Wire via Yahoo!7 Finance)
REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com) announced today that it has received official notice from the Hong Kong Intellectual Property Department granting a patent using TB4, analogues, isoforms and derivatives to accelerate corneal wound healing and reverse or inhibit eye degeneration.